BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. (FWB: BM8) is trading at €52.58, about ₹5,723 at today's EUR/INR rate, as of 30 Sep 2026, 2:00 AM ET, up 1.27% today. Indian residents can buy BioMarin Pharmaceutical from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
€52.58
Today's high
€52.58
52 week low
€42.62
52 week high
€60.74
BM8 opened at €52.58, closed previously at €51.92, and has traded between €42.62 and €60.74 over the past 52 weeks.
About
BioMarin Pharmaceutical Inc. operates as a leading biopharmaceutical firm, concentrating on the creation and worldwide commercialization of therapeutic interventions for critical, rare medical conditions and life-threatening diseases. Its market reach extends across the United States, Europe, Latin America, the Middle East, and the Asia Pacific region. The company's current portfolio features several key medications: VIMIZIM, an enzyme replacement therapy for mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder. VOXZOGO, a once-daily injectable analog of c-type natriuretic peptide (CNP), approved for achondroplasia. NAGLAZYME, a recombinant form of N-acetylgalactosamine 4-sulfatase, prescribed for patients with MPS VI. PALYNZIQ, a PEGylated recombinant phenylalanine (Phe) ammonia lyase enzyme, delivered subcutaneously to lower blood Phe levels. BRINEURA, a recombinant human tripeptidyl peptidase 1, indicated for ceroid lipofuscinosis type 2, a type of Batten disease. ALDURAZYME, a purified protein designed to replicate the naturally occurring human enzyme alpha-L-iduronidase. KUVAN, a proprietary synthetic oral variant of 6R-BH4, employed to manage phenylketonuria, an inherited metabolic illness. ROCTAVIAN, an adeno-associated virus (AAV) vector-based treatment for severe hemophilia A. Beyond its marketed products, BioMarin maintains an active development pipeline. This includes BMN 333, a longer-acting CNP aimed at various growth disorders like achondroplasia and hypochondroplasia; BMN 349, an experimental oral therapeutic for liver disease associated with alpha-1 antitrypsin deficiency; and BMN 351, an oligonucleotide under investigation for Duchenne muscular dystrophy. The company's distribution channels encompass specialty pharmacies, hospitals, non-U.S. government entities, distributors, and pharmaceutical wholesalers. BioMarin also holds licensing and collaborative agreements with partners such as Catalyst Pharmaceutical Partners, Inc. and Ares Trading S.A. Established in 1996, the company's corporate headquarters are located in San Rafael, California.
Key statistics
Avg. volume
287.00
Market cap
€10.16B
P/E Ratio
157.89
Price-to-sales ratio
3.40
Enterprise value
—
Free cash flow yield
—
Debt-to-equity ratio
0.66
Return on equity
—
ROIC
—
Beta
0.24
Dividend yield
0.00%
Last dividend
€0.00
Financial overview
Revenue
—
Earnings per share
—
Free cash flow
—
Net profit margin
2.14%
Gross margin
75.55%
EBITDA
—
Revenue growth
—
How to buy BioMarin Pharmaceutical from India
Indian residents can buy BioMarin Pharmaceutical shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to EUR.
Search for BioMarin Pharmaceutical and place an order
Find BioMarin Pharmaceutical by name or by its ticker, BM8, and choose an order type. BioMarin Pharmaceutical trades 11:30 am – 11:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your BioMarin Pharmaceutical position in EUR and INR. BioMarin Pharmaceutical pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in BioMarin Pharmaceutical from India
Trading and taxes when buying BioMarin Pharmaceutical from India
Trading and limits
- Trading hours
- 8:00 am – 8:00 pm CET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneBioMarin Pharmaceutical does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy BioMarin Pharmaceutical stock?
Yes. BioMarin Pharmaceutical (BM8) has been listed on the Frankfurt Stock Exchange since 2000, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to EUR. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one BioMarin Pharmaceutical share cost in rupees?
One BioMarin Pharmaceutical share is €52.58 — about ₹5,723 at an EUR/INR rate of 108.84 on 30 Sep 2026. Both the BioMarin Pharmaceutical price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying BioMarin Pharmaceutical from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on BioMarin Pharmaceutical shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the EUR/INR rate on the purchase and the sale date, so the rupee move counts alongside the BioMarin Pharmaceutical price. Paasa issues a capital-gains statement for your return.
Does BioMarin Pharmaceutical pay a dividend?
No. BioMarin Pharmaceutical does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade BioMarin Pharmaceutical from India?
The Frankfurt Stock Exchange trades 11:30 am – 11:30 pm IST in Indian time. The window shifts to 12:30 pm – 12:30 am IST when Germany is on standard time. Orders can only execute during that window.
Is BioMarin Pharmaceutical a Germany company, and does that change how it is taxed?
BioMarin Pharmaceutical trades on the Frankfurt Stock Exchange in EUR, but the company is domiciled in United States. BioMarin Pharmaceutical trades as an ordinary share listed directly in Germany, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare BioMarin Pharmaceutical shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your BioMarin Pharmaceutical holding, its cost and its closing value.
How do I sell BioMarin Pharmaceutical and bring the money back to India?
You sell during market hours (11:30 am – 11:30 pm IST) and the proceeds settle in EUR in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.
Does the rupee rate affect what I make on BioMarin Pharmaceutical?
Yes. BioMarin Pharmaceutical is priced in EUR, so your rupee outcome combines the EUR move with the EUR/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.